In 2024, the market for immunity-boosting food products in the Asia Pacific region expanded, driven by heightened consumer awareness about health and wellness. The COVID-19 pandemic led to an increased focus on immunity, with markets such as China, India, Japan, South Korea, Australia, and ASEAN countries reflecting strong demand for such products. Government-initiated health campaigns, particularly in India and Australia, amplified public cognizance about proactive health care. E-commerce platforms, including Alibaba and Flipkart.
Meanwhile, technology adoption in precision nutrition, such as the WeChat Health Program in China, facilitated personalized dietary recommendations, strengthening consumer engagement. The trend of incorporating traditional herbs into everyday foods, a prevalent practice in China and India, found acceptance across other markets, with brands launching 'fusion' products. Furthermore, partnerships between food manufacturing and pharmaceutical companies, like in Japan and South Korea, saw an influx of immunity products in the retail sector. However, regulatory enforcement for product labeling and health claim substantiation had a positive influence, guiding consumer choices towards scientifically validated products.